{"disease":{"id":"insulinoma","name":"Insulinoma","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"diazoxide","indication_name":"Insulinoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Proglycem","generic_name":"DIAZOXIDE","company_name":"","drug_phase":"marketed","molecular_target":"Sulfonylurea receptor 1, Kir6.2","drug_class":"diazoxide","quality_score":55,"revenue":null,"mechanism":"Proglycem works by blocking the ATP-sensitive potassium channel, which helps to increase blood sugar levels and reduce insulin secretion."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00001276","title":"Diagnosing and Treating Low Blood Sugar Levels","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT03583528","title":"DOTATOC PET/CT for Imaging NET Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":800,"lead_sponsor_name":"British Columbia Cancer Agency","has_results":false},{"nct_id":"NCT06725693","title":"Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Tianjin Medical University","has_results":false},{"nct_id":"NCT01010126","title":"Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":252,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT07272187","title":"Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions","phase":"","overall_status":"RECRUITING","enrollment_count":138,"lead_sponsor_name":"Herlev Hospital","has_results":false},{"nct_id":"NCT04979611","title":"The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"First Affiliated Hospital of Fujian Medical University","has_results":false},{"nct_id":"NCT05735912","title":"EUS-RFA Versus Surgery for Pancreatic Insulinoma (ERASIN-RCT)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Integrata Verona","has_results":false},{"nct_id":"NCT04185350","title":"Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Nanjing First Hospital, Nanjing Medical University","has_results":false},{"nct_id":"NCT07340437","title":"Clinical Study of 18F-Exendin-4 in Insulinoma","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Sichuan Provincial People's Hospital","has_results":false},{"nct_id":"NCT05034783","title":"[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT03147768","title":"Laser Tissue Welding - Distal Pancreatectomy Sealing Study","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Laser Tissue Welding, Inc.","has_results":false},{"nct_id":"NCT04452396","title":"CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia","phase":"NA","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Barts & The London NHS Trust","has_results":false},{"nct_id":"NCT02259725","title":"Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"University of Southern California","has_results":true},{"nct_id":"NCT02031536","title":"Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"ECOG-ACRIN Cancer Research Group","has_results":true},{"nct_id":"NCT04915144","title":"177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"British Columbia Cancer Agency","has_results":false},{"nct_id":"NCT02431715","title":"18F-FDOPA PET in Neuroendocrine Tumours","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"British Columbia Cancer Agency","has_results":false},{"nct_id":"NCT01916148","title":"18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false}],"total":17},"guidelines":[],"source":"Drug Landscape verified database"}